Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4649235
Max Phase: Preclinical
Molecular Formula: C80H118N20O20S
Molecular Weight: 1712.01
Molecule Type: Unknown
Associated Items:
ID: ALA4649235
Max Phase: Preclinical
Molecular Formula: C80H118N20O20S
Molecular Weight: 1712.01
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(N)=O
Standard InChI: InChI=1S/C80H118N20O20S/c1-10-42(6)65(79(119)98-54(33-46-23-15-12-16-24-46)73(113)93-56(35-60(82)102)70(110)88-43(7)67(86)107)99-69(109)51(28-30-121-9)90-74(114)55(34-47-39-87-49-26-18-17-25-48(47)49)92-68(108)50(27-19-20-29-81)89-72(112)53(32-45-21-13-11-14-22-45)91-71(111)52(31-40(2)3)97-80(120)66(44(8)101)100-77(117)58(37-62(84)104)94-76(116)59(38-63(105)106)95-75(115)57(36-61(83)103)96-78(118)64(85)41(4)5/h11-18,21-26,39-44,50-59,64-66,87,101H,10,19-20,27-38,81,85H2,1-9H3,(H2,82,102)(H2,83,103)(H2,84,104)(H2,86,107)(H,88,110)(H,89,112)(H,90,114)(H,91,111)(H,92,108)(H,93,113)(H,94,116)(H,95,115)(H,96,118)(H,97,120)(H,98,119)(H,99,109)(H,100,117)(H,105,106)/t42-,43-,44+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,64-,65-,66-/m0/s1
Standard InChI Key: NAHPFAXSKDPUGZ-VBFPKMDTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1712.01 | Molecular Weight (Monoisotopic): 1710.8552 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Saitoh M, Takayama K, Hitachi K, Taguchi A, Taniguchi A, Tsuchida K, Hayashi Y.. (2020) Discovery of a follistatin-derived myostatin inhibitory peptide., 30 (3): [PMID:31874826] [10.1016/j.bmcl.2019.126892] |
Source(1):